$17.35
0.231.34%
In chiusura: Nov 13, 4:00 PM EST
$17.35
0.231.34%
Pre-mercato: 7:00 AM EST

Carlsmed (CARL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 10, 2026 | $-0.34 | $-0.39 | 12.8 % |
| Q2 | Aug 5, 2026 | $-0.39 | $-0.38 | -2.63 % |
| Q1 | May 5, 2026 | $-0.32 | $-0.40 | 20.0 % |
| Q4 | Feb 25, 2026 | $-0.32 | $-0.43 | 25.6 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 10, 2026 | $21.55M | $19.25M | 12.0 % |
| Q2 | Aug 5, 2026 | $18.94M | $18.08M | 4.78 % |
| Q1 | May 5, 2026 | $16.10M | $14.86M | 8.37 % |
| Q4 | Feb 25, 2026 | $15.17M | $14.86M | 2.07 % |
Carlsmed (CARL) ha pubblicato l'ultima guidance il novembre 10, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $78M - $80M per il periodo.
Rispetto alle previsioni precedenti, Carlsmed ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Carlsmed ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Carlsmed. 9
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.39 | $-0.38 | $-0.40 | $-0.43 |
| Actual | $-0.34 | $-0.39 | $-0.32 | $-0.32 |
| Surprise | +12.8% | -2.63% | +20.0% | +25.6% |
| Revenue | ||||
| Estimate | $19.2M | $18.1M | $14.9M | $14.9M |
| Actual | $21.6M | $18.9M | $16.1M | $15.2M |
| Surprise | +12.0% | +4.78% | +8.37% | +2.07% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.36 | $-0.35 | $-0.38 | $-0.40 |
| Revenue | ||||
| Consensus | $23.9M | $24.6M | — | — |